1 / 1

52 discontinued: AE 1 Lack of efficacy 32 Protocol deviation 7 Lost to Follow-up 0

1110 patients screened. Excluded (n=499) 379 failed screening a 120 failed run in b. 610 randomized c. 609 (ITT population). 203 received placebo OD . 205 received FF 100mcg OD. 201 received FF/VI 100/25mcg OD. 22 discontinued: AE 2 Lack of efficacy 7 Protocol deviation 2

emilia
Télécharger la présentation

52 discontinued: AE 1 Lack of efficacy 32 Protocol deviation 7 Lost to Follow-up 0

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 1110 patients screened Excluded (n=499) 379 failed screeninga120 failed run inb 610 randomizedc 609 (ITT population) 203 received placebo OD 205received FF 100mcg OD 201 received FF/VI 100/25mcg OD 22 discontinued:AE 2 Lack of efficacy 7 Protocol deviation 2 Lost to Follow-up 2 Investigator discretion 6Withdrew consent 3 52 discontinued:AE 1 Lack of efficacy 32 Protocol deviation 7 Lost to Follow-up 0 Investigator discretion 6 Withdrew consent 6 20 discontinued:AE 0 Lack of efficacy 6 Protocol deviation 0 Lost to Follow-up 1 Investigator discretion 7 Withdrew consent 6 151 completed the study 185 completed the study 179 completed the study

More Related